DANVILLE, PA -- Geisinger’s research effort has been accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), the Washington, D.C.-based organization announced Thursday. Geisinger is one of eight newly accredited organizations to have demonstrated its commitment to protecting human subjects in research.
Geisinger now joins such organizations as the National Institutes of Health, the Baylor College of Medicine, and global pharmaceutical giant Pfizer in holding AAHRPP accreditation, which denotes a commitment to quality surpassing that of state and federal requirements.
To earn the accreditation, organizations must not only adhere to high standards of research, but demonstrate that they have built extensive safeguards into every level of their research operation. Geisinger’s Human Research Protection Program comprises the Institutional Review Board (IRB), the Office of Research Compliance, the Office of Sponsored Projects, and various oversight, education, and quality assurance review units, including program administration.
“This accreditation underscores the commitment Geisinger has to continuing high quality, ethical research practices and the strong desire we have to translate these efforts into practical benefits for our patients,” said IRB Co-Chair Thomas D. Challman, M.D.
Dorothy C. Sellers, Geisinger Director of Research Compliance and Training, said: “This is a very exciting time to be involved in research at Geisinger and receiving this accreditation demonstrates Geisinger’s commitment to ‘making it the best.’”
In today’s global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners. “AAHRPP accreditation standards have earned a reputation as the benchmark for quality human research protection programs,” AAHRPP President and CEO Elyse I. Summers said. “As a result, we continue to see strong interest in accreditation from organizations across the research spectrum and around the globe,” she said.
To date, 227 organizations have earned AAHRPP accreditation. Of these, 32 are located outside the United States. All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more than 60 percent of U.S. research-intensive universities and over 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process.
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.